Search results for "CARDIOVASCULAR DISEASE."

showing 10 items of 2331 documents

Sex Differences in Severity of Stroke in the INSTRUCT Study: a Meta‐Analysis of Individual Participant Data

2018

Background Women have worse outcomes after stroke than men, and this may be partly explained by stroke severity. We examined factors contributing to sex differences in severity of acute stroke assessed by the National Institutes of Health Stroke Scale. Methods and Results We pooled individual participant data with National Institutes of Health Stroke Scale assessment (N=6343) from 8 population‐based stroke incidence studies (1996–2014), forming part of INSTRUCT (International Stroke Outcomes Study). Information on sociodemographics, stroke‐related clinical factors, comorbidities, and pre‐stroke function were obtained. Within each study, relative risk regression using log‐binominal modeling…

medicine.medical_specialtysex differencePopulation030204 cardiovascular system & hematologyGlobal HealthRisk AssessmentSeverity of Illness IndexBrain IschemiaBrain ischemia03 medical and health sciences0302 clinical medicineRisk FactorsInternal medicineEpidemiologySeverity of illnessmedicineHumanscardiovascular diseasesSex DistributioneducationStrokeIntracerebral hemorrhageeducation.field_of_studyQuality and OutcomesSystematic Review and Meta‐analysisbusiness.industryIncidenceMeta Analysismedicine.diseasestrokeMeta-analysisRelative riskepidemiologyCardiology and Cardiovascular Medicinebusiness030217 neurology & neurosurgeryJournal of the American Heart Association
researchProduct

TCTAP A-059 Intrahospital and Long-term Outcomes After True Bifurcation Stenting

2019

Bifurcation percutaneous coronary intervention (PCI) is challenging and is associated with lower rate of procedural success and higher risk of complications. The aim of this study was to evaluate intrahospital and long-term outcomes of patients who underwent PCI for bifurcation lesions involving

medicine.medical_specialtysurgical procedures operativebusiness.industrymedicine.medical_treatmentInternal medicineConventional PCImedicineCardiologyLong term outcomesPercutaneous coronary interventioncardiovascular diseasesCardiology and Cardiovascular MedicinebusinessJournal of the American College of Cardiology
researchProduct

Immunoglobulin E (IgE) and ischemic heart disease. Which came first, the chicken or the egg?

2014

Several lines of evidence demonstrate that the immune system plays a pivotal role in development and progression of ischemic heart disease (IHD). More recently, a series of biological and clinical investigations has generated new interest about the existence of a relationship between a specific class of immunoglobulin, that is immunoglobulin E (IgE), and IHD. Data obtained in several epidemiological studies have convincingly demonstrated that the concentration of total serum IgEs is significantly increased in patients with IHD and often correlates with the prognosis. The putative mechanisms are essentially mediated by a physiological interaction between IgEs and mast cells, which triggers t…

medicine.medical_treatmentCoronary Vessel AnomaliesMyocardial IschemiaDiseaseImmunoglobulin Eimmunoglobulin EPathogenesisImmune systemMedicineHumanscardiovascular diseasesMyocardial infarctionMast Cellsischemic heart disease; immunoglobulin E; immune systembiologybusiness.industryGeneral MedicineImmunotherapymedicine.diseaseischemic heart diseaseIncreased IgE levelimmune systemImmunologybiology.proteinAntibodybusinessJob Syndrome
researchProduct

Is COVID‐19 infection more severe in kidney transplant recipients?

2021

International audience; There are no studies which have compared the risk of severe Covid-19 and related mortality between transplant recipients and non-transplant patients. We enrolled two groups of patients hospitalized for Covid-19, i.e., kidney transplant recipients from the French Registry of Solid Organ Transplant (n=306) and a single-center cohort of non-transplant patients (n=795). An analysis was performed among subgroups matched for age and risk factors for severe Covid-19 or mortality. Severe Covid-19 was defined as admission (or transfer) to an intensive care unit, need for mechanical ventilation, or death.Transplant recipients were younger and had more comorbidities compared to…

medicine.medical_treatment[SDV]Life Sciences [q-bio]MESH: Registries*AucunMESH: Comorbidity030230 surgerylaw.inventionchemistry.chemical_compound0302 clinical medicinelawcardiovascular diseaseMESH: Risk Factors[SDV.MHEP.MI]Life Sciences [q-bio]/Human health and pathology/Infectious diseasesclinical research / practiceImmunology and AllergyCumulative incidencePharmacology (medical)kidney transplantation / nephrologyMESH: IncidenceMESH: AgedUnivariate analysisMESH: France / epidemiologyMESH: Middle AgedMESH: Transplant Recipients / statistics & numerical data*Acute kidney injuryIntensive care unit3. Good healthMESH: COVID-19 / epidemiologyCohort[SDV.MHEP.MI] Life Sciences [q-bio]/Human health and pathology/Infectious diseasesglomerular filtration rate (GFR)kidney failure / injurymedicine.medical_specialtyinfection and infectious agents - viralinfectious diseaseBrief CommunicationMESH: Graft Rejection / prevention & control03 medical and health sciencesInternal medicineDiabetes mellitusMESH: Severity of Illness IndexMESH: COVID-19 / diagnosis*medicineHumansMESH: SARS-CoV-2Mechanical ventilationCreatinineTransplantationMESH: Humansbusiness.industrySARS-CoV-2MESH: Graft Rejection / epidemiology*COVID-19MESH: Retrospective Studiesmedicine.diseaseKidney TransplantationTransplant RecipientsMESH: Maleimmunosuppressive regimensMESH: Immunosuppressive Agents / therapeutic useMESH: Pandemics*MESH: Propensity Score*chemistryReinfectionMESH: Immunosuppression / methodsMESH: Intensive Care UnitsbusinessMESH: FemaleMESH: Kidney Transplantation*
researchProduct

Intrahematomal Ultrasound Enhances RtPA-Fibrinolysis in a Porcine Model of Intracerebral Hemorrhage

2021

Catheter-based ultrasound-thrombolysis has been successfully used in a small clinical trial in order to enhance recombinant tissue plasminogen activator (rtPA)-fibrinolysis, for the treatment of spontaneous intracerebral hemorrhages (ICHs). The aim of this study was to investigate the ultra-early effects of ultrasound on hematoma and the surrounding brain tissue in a porcine ICH-model. To achieve this, 21 pigs with a right frontal ICH were randomly assigned to four groups: (1) drainage (n = 3), (2) drainage + rtPA (n = 6), (3) drainage + ultrasound (n = 6), and (4) drainage + ultrasound + rtPA (n = 6). The hematoma volume assessment was performed using cranial MRI before and after the treat…

medicine.medical_treatmentlcsh:Medicine030204 cardiovascular system & hematologyArticle03 medical and health sciences0302 clinical medicineHematomaEdemartPA-fibrinolysisFibrinolysismedicineminimally invasive therapycardiovascular diseasesIntracerebral hemorrhagebusiness.industryUltrasoundlcsh:RGeneral Medicinemedicine.diseaseintracerebral hemorrhageCatheterImmunohistochemistrymedicine.symptombusinessNuclear medicinePerfusion030217 neurology & neurosurgeryultrasound-thrombolysisJournal of Clinical Medicine
researchProduct

Pharmacokinetics of new oral anticoagulants: implications for use in routine care

2018

Introduction: Since 2008, new oral anticoagulants (NOACs) have been approved for the prevention of venous thromboembolism (VTE) in patients receiving hip or knee replacement surgery, prevention of stroke and systemic embolism in patients with non-valvular atrial fibrillation (NVAF), treatment of deep vein thrombosis (DVT), and pulmonary embolism (PE). Premarketing randomized clinical trials (RCTs) of NOACs demonstrated their non-inferiority in terms of efficacy vs. warfarin (traditional oral anticoagulant–TOA), with lower risk of serious adverse drug reactions, especially cerebral hemorrhages. In clinical practice, pharmacokinetic aspects of NOACs have to be carefully taken into account to …

medicine.medical_treatmentnew oral anticoagulantsAdministration OralKnee replacement030204 cardiovascular system & hematologyToxicologyAdherence Bleeding Interactions New oral anticoagulants Over- and under-dosage Persistence Pharmacokinetics Real World Evidence0302 clinical medicineAtrial Fibrillationover- and underdosage030212 general & internal medicinepharmacokineticStrokeRoutine careRandomized Controlled Trials as Topicnew oral anticoagulantAtrial fibrillationpersistenceVenous ThromboembolismGeneral MedicinePulmonary embolismStrokepharmacokineticsHumanmusculoskeletal diseasesmedicine.medical_specialtyinteractionHemorrhageMedication Adherence03 medical and health sciencesPharmacokineticsmedicineHumansReal World EvidenceIn patientOver- and under-dosagecardiovascular diseasesreal-world evidenceIntensive care medicineAgedPharmacologybusiness.industryAnticoagulantAnticoagulantsinteractionsbleedingmedicine.diseaseAdherencePulmonary EmbolismbusinessVenous thromboembolismExpert Opinion on Drug Metabolism & Toxicology
researchProduct

European guidelines on chronic mesenteric ischaemia - joint United European Gastroenterology, European Association for Gastroenterology, Endoscopy an…

2020

Chronic mesenteric ischaemia is a severe and incapacitating disease, causing complaints of post-prandial pain, fear of eating and weight loss. Even though chronic mesenteric ischaemia may progress to acute mesenteric ischaemia, chronic mesenteric ischaemia remains an underappreciated and undertreated disease entity. Probable explanations are the lack of knowledge and awareness among physicians and the lack of a gold standard diagnostic test. The underappreciation of this disease results in diagnostic delays, underdiagnosis and undertreating of patients with chronic mesenteric ischaemia, potentially resulting in fatal acute mesenteric ischaemia. This guideline provides a comprehensive overvi…

mesenteric artery stentingComputed Tomography AngiographyFOCUSED UPDATEContrast MediaARTERY COMPRESSION SYNDROMEDiseaseGuidelineSettore MED/22 - Chirurgia VascolareSeverity of Illness Indexatherosclerosi0302 clinical medicineIschemiaMesenteric Vascular Occlusionatherosclerosis; coeliac artery release; Median arcuate ligament syndrome; mesenteric arteries; mesenteric artery stenting610 Medicine & healthMesenteric arteriesmesenteric arteriesSocieties MedicalNetherlandsSUPERIOREvidence-Based MedicineGASTRIC EXERCISE TONOMETRYmedicine.diagnostic_testGastroenterologyDUAL ANTIPLATELET THERAPYENHANCED MR-ANGIOGRAPHYEuropeTreatment Outcomemedicine.anatomical_structureOncology030220 oncology & carcinogenesisRadiological weaponSURGICAL-TREATMENT030211 gastroenterology & hepatologyRadiologyMedian arcuate ligament syndromeSTENT PLACEMENTmedicine.medical_specialtyANTITHROMBOTIC THERAPYMedian arcuate ligament syndromeRisk Assessment03 medical and health sciencescoeliac artery releasemedicineHumanscardiovascular diseasesIntensive care medicinePatient Care TeamMEDIAN ARCUATE LIGAMENTbusiness.industryGold standardEndoscopyGuidelinemesenteric arteriemedicine.diseaseEndoscopyMesenteric ischemiaMesenteric IschemiaChronic DiseaseInterdisciplinary CommunicationatherosclerosisbusinessMagnetic Resonance Angiography
researchProduct

Endoplasmic Reticulum Stress and miRNA Impairment in Aging and Age-Related Diseases

2021

Aging is a physiological process defined by decreased cellular and tissue functions. Reduced capacity of protein degradation is one of the important hallmarks of aging that may lead to misfolded protein accumulation and progressive loss of function in organ systems. Recognition of unfolded/misfolded protein aggregates via endoplasmic reticulum (ER) stress sensors activates an adaptive mechanism, the unfolded protein response (UPR). The initial step of UPR is defined by chaperone enhancement, ribosomal translation suppression, and misfolded protein degradation, while prolonged ER stress triggers apoptosis. MicroRNAs (miRNAs) are non-coding RNAs affecting various signaling pathways through de…

microRNAGeriatricsagingendoplasmic reticulum stressRC952-954.6metabolic disordersneurodegenerative diseasescardiovascular diseasesFrontiers in Aging
researchProduct

Acute heart failure due to giant left atrium: remote ECLS implantation for interhospital transfer and bridging to decision

2018

AbstractBackgroundRemote extracorporeal life support (ECLS) implantation and mobile ECLS are increasingly applied to enable the treatment of patients with refractory heart failure at specialized care centers. Giant left atrium (GLA) is a rare cause but may lead to acute and devastating heart failure.Case reportAcute heart failure that gave rise to a prolonged period of out-of-hospital cardiopulmonary resuscitation in a patient who underwent remote ECLS implantation was found to have resulted from a GLA of impressive dimensions. There having no reasonable option for immediate surgical therapy, the patient was successfully bridged to recovery with a view to subsequent heart transplantation.Co…

mobile ECLSHeart transplantationendocrine systemmedicine.medical_specialtyRD1-811business.industrymedicine.medical_treatmentheart failureCase Reportremote ECLS implantationmedicine.diseaseGiant left atriumextracorporeal life supportExtracorporealSurgerygiant left atriumHeart failureLife supportMedicineSurgeryIn patientcardiovascular diseasesCardiopulmonary resuscitationbusinessRefractory heart failureInnovative Surgical Sciences
researchProduct

The role of osteoprotegerin in the crosstalk between vessels and bone: Its potential utility as a marker of cardiometabolic diseases

2018

International audience; Among the numerous molecules that are being studied for their potential utility as biomarkers of cardiovascular diseases, much interest has been shown in the superfamily of tumor necrosis factor (TNF) receptors. Members of this family include osteoprotegerin (OPG) and its ligands, which are receptor activators of nuclear factor κB ligand (RANKL) and TNF-related apoptosis-inducing ligand (TRAIL). These signals may be expressed and regulated, and their functions could be involved in several physiological and pathological processes. The relationship between bone regulatory proteins and vascular biology has attracted attention, and it has been suggested that OPG may medi…

musculoskeletal diseases0301 basic medicinemedicine.medical_specialtyOsteoporosisInflammationDisease030204 cardiovascular system & hematologyBone remodeling03 medical and health sciences0302 clinical medicine[SDV.MHEP.CSC]Life Sciences [q-bio]/Human health and pathology/Cardiology and cardiovascular systemOsteoprotegerinInternal medicinemedicineHumans[SDV.BBM]Life Sciences [q-bio]/Biochemistry Molecular BiologyPharmacology (medical)Vascular CalcificationReceptorPharmacologybiologyChemistryOsteoprotegerinmedicine.disease3. Good health030104 developmental biologyEndocrinologyCardiovascular DiseasesRANKLbiology.proteinTumor necrosis factor alphaBone Remodelingmedicine.symptomPharmacology & Therapeutics
researchProduct